Inventor
DRAPER KENNETH G
US39 patents
⚠️ This page may combine multiple inventors who share the name “DRAPER KENNETH G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIBOZYME PHARM INC
30 patentsUS5972704AOct 26, 1999
HIV nef targeted ribozymes
RIBOZYME PHARM INC221 citations99
US5869253AFeb 9, 1999
Method and reagent for inhibiting hepatitis C virus replication
RIBOZYME PHARM INC226 citations99
US5610054AMar 11, 1997
Enzymatic RNA molecule targeted against Hepatitis C virus
RIBOZYME PHARM INC165 citations99
US6410224B1Jun 25, 2002
Ribozyme treatment of diseases or conditions related to levels of NF-κB
RIBOZYME PHARM INC48 citations96
US6017756AJan 25, 2000
Method and reagent for inhibiting hepatitis B virus replication
RIBOZYME PHARM INC79 citations96
US5972699AOct 26, 1999
Method and reagent for inhibiting herpes simplex virus replication
RIBOZYME PHARM INC53 citations96
US5750390AMay 12, 1998
Method and reagent for treatment of diseases caused by expression of the bcl-2 gene
RIBOZYME PHARM INC68 citations96
US5693535ADec 2, 1997
HIV targeted ribozymes
RIBOZYME PHARM INC84 citations96
US5496698AMar 5, 1996
Method of isolating ribozyme targets
RIBOZYME PHARM INC132 citations95
US5731295AMar 24, 1998
Method of reducing stromelysin RNA via ribozymes
RIBOZYME PHARM INC59 citations94
US6132966AOct 17, 2000
Method and reagent for inhibiting hepatitis C virus replication
RIBOZYME PHARM INC20 citations93
US5639655AJun 17, 1997
PML-RARA targeted ribozymes
RIBOZYME PHARM INC34 citations93
US5622854AApr 22, 1997
Method and reagent for inhibiting T-cell leukemia virus replication
RIBOZYME PHARM INC19 citations93
US5616488AApr 1, 1997
IL-5 targeted ribozymes
RIBOZYME PHARM INC23 citations93
US5610052AMar 11, 1997
Enzymatic RNA with activity to ras
RIBOZYME PHARM INC19 citations93
US5837542ANov 17, 1998
Intercellular adhesion molecule-1 (ICAM-1) ribozymes
RIBOZYME PHARM INC20 citations92
US5616490AApr 1, 1997
Ribozymes targeted to TNF-α RNA
RIBOZYME PHARM INC32 citations92
US5612215AMar 18, 1997
Stromelysin targeted ribozymes
RIBOZYME PHARM INC19 citations91
US5658780AAug 19, 1997
Rel a targeted ribozymes
RIBOZYME PHARM INC14 citations82
US5599704AFeb 4, 1997
ErbB2/neu targeted ribozymes
RIBOZYME PHARM INC17 citations82
US6258585B1Jul 10, 2001
Method and reagent for inhibiting influenza virus replication
RIBOZYME PHARM INC14 citations74
US6159692ADec 12, 2000
Method and reagent for inhibiting human immunodeficiency virus replication
RIBOZYME PHARM INC8 citations74
US5801158ASep 1, 1998
Enzymatic RNA with activity to RAS
RIBOZYME PHARM INC8 citations74
US5795778AAug 18, 1998
Method and reagent for inhibiting herpes simplex virus replication
RIBOZYME PHARM INC6 citations74
US6544755B1Apr 8, 2003
Method and reagent for treatment of diseases by expression of the c-Myc gene
RIBOZYME PHARM INC2 citations63
US6440719B1Aug 27, 2002
Method and reagent for inhibiting herpes simplex virus replication
RIBOZYME PHARM INC3 citations63
US6436644B1Aug 20, 2002
Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)
RIBOZYME PHARM INC2 citations63
US6432704B1Aug 13, 2002
Method and reagent for inhibiting herpes simplex virus replication
RIBOZYME PHARM INC3 citations63
US6132967AOct 17, 2000
Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)
RIBOZYME PHARM INC2 citations63
US6492512B1Dec 10, 2002
Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression
RIBOZYME PHARM INC1 citations52
ISIS PHARMACEUTICALS INC
8 patentsUS5248670ASep 28, 1993
Antisense oligonucleotides for inhibiting herpesviruses
ISIS PHARMACEUTICALS INC140 citations99
US5514577AMay 7, 1996
Oligonucleotide therapies for modulating the effects of herpes viruses
ISIS PHARMACEUTICALS INC153 citations98
US5591720AJan 7, 1997
Oligonucleotides for modulating the effects of cytomegalovirus infections
ISIS PHARMACEUTICALS INC83 citations96
US5658891AAug 19, 1997
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC36 citations93
US5595978AJan 21, 1997
Composition and method for treatment of CMV retinites
ISIS PHARMACEUTICALS INC31 citations88
US6310044B1Oct 30, 2001
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC10 citations74
US5767102AJun 16, 1998
Antisense composition and method for treatment of CMV infection
ISIS PHARMACEUTICALS INC7 citations69
US6153595ANov 28, 2000
Composition and method for treatment of CMV infections
ISIS PHARMACEUTICALS INC8 citations68